Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials by Andrew R. DiNardo, Andrew R. DiNardo, Wilbert Sabiiti, Stephen H. Gillespie, Sophia B. Georghiou, Norbert Heinrich, Norbert Heinrich, Norbert Hittel, Sami Taghlabi, Danna Carrero Longlax, Mikashmi Kohli, Ursula Panzner, Ursula Panzner, Collins Musia, Christoph Lange, Christoph Lange, Christoph Lange, Christoph Lange, Anca Vasiliu, Anca Vasiliu, Anca Vasiliu, Rob J. W. Arts, Anna M. Mandalakas, Anna M. Mandalakas, Anna M. Mandalakas, Morten Ruhwald, Lieven J. Stuyver, Reinout van Crevel, Reinout van Crevel

Get full text